Pharma

Your Article Summary

See Latest Articles

FDA Classifies Medtronic Voluntary February Recall for Intrepid Intervertebral Body Fusion Device as Class II
Medtronic, 07/24/09

Medtronic, Inc. announced that the U.S. Food and Drug Administration has classified its voluntary recall action of the Intrepid Intervertebral Body Fusion Device as a Class II recall. Medtronic initiated a voluntary recall of the product on February 2009, and communicated the risk to physicians and hospitals. As of the date of this news release, all unused product has been retrieved and Medtronic has received confirmation of notification from all affected physicians and hospitals.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
PLoS Medicine, 12/02/09

FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09

Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
GlaxoSmithKline, 12/01/09

 See all of Regulatory Issues